Challenges and opportunities for further research involving the cannabis-to-opioid use transition
| Errataetall: |
CommentOn: Addiction. 2022 Feb;117(2):284-298. - PMID 34264545 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:117 |
|---|---|
| Enthalten in: |
Addiction (Abingdon, England) - 117(2022), 10 vom: 06. Okt., Seite 2752-2754 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bahji, Anees [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Analgesics |
|---|
| Anmerkungen: |
Date Completed 08.09.2022 Date Revised 25.02.2023 published: Print-Electronic CommentOn: Addiction. 2022 Feb;117(2):284-298. - PMID 34264545 Citation Status MEDLINE |
|---|
| doi: |
10.1111/add.15973 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM341831867 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341831867 | ||
| 003 | DE-627 | ||
| 005 | 20231226012659.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/add.15973 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1139.xml |
| 035 | |a (DE-627)NLM341831867 | ||
| 035 | |a (NLM)35661297 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bahji, Anees |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Challenges and opportunities for further research involving the cannabis-to-opioid use transition |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.09.2022 | ||
| 500 | |a Date Revised 25.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Addiction. 2022 Feb;117(2):284-298. - PMID 34264545 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a Cannabis | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Opioid-Related Disorders | |
| 650 | 4 | |a Pharmacoepidemiology | |
| 650 | 4 | |a meta-analysis | |
| 650 | 4 | |a opioids | |
| 650 | 7 | |a Analgesics |2 NLM | |
| 650 | 7 | |a Analgesics, Opioid |2 NLM | |
| 650 | 7 | |a Medical Marijuana |2 NLM | |
| 700 | 1 | |a Milloy, Michael John |e verfasserin |4 aut | |
| 700 | 1 | |a Bach, Paxton |e verfasserin |4 aut | |
| 700 | 1 | |a Sociás, Maria Eugenia |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Addiction (Abingdon, England) |d 1993 |g 117(2022), 10 vom: 06. Okt., Seite 2752-2754 |w (DE-627)NLM075102978 |x 1360-0443 |7 nnns |
| 773 | 1 | 8 | |g volume:117 |g year:2022 |g number:10 |g day:06 |g month:10 |g pages:2752-2754 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/add.15973 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 117 |j 2022 |e 10 |b 06 |c 10 |h 2752-2754 | ||